Nutrition and Crohn's disease: An update of print and Web-based guidance

Nutrition Reviews

Volumn 66, Issue 7, 2008, Pages 387-397

  Moorthy, Denish ^a   Cappellano, Kathleen L ^b   Rosenberg, Irwin H ^a  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

Crohn's disease; Nutrition

Indexed keywords

ANTIOXIDANT; CALCIUM; CALCIUM CARBONATE; COPPER ZINC SUPEROXIDE DISMUTASE; CYANOCOBALAMIN; FISH OIL; FOLIC ACID; GLUTAMINE; IRON; MAGNESIUM; OMEGA 3 FATTY ACID; PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT; VITAMIN D;

CLINICAL TRIAL; CROHN DISEASE; DIET THERAPY; DIETARY FIBER; ENTERIC FEEDING; GROWTH RETARDATION; HUMAN; INTERNET; IRON DEFICIENCY; MAGNESIUM DEFICIENCY; MEDICAL LITERATURE; MULTIMEDIA; NUTRITION; NUTRITIONAL DEFICIENCY; OSTEOMALACIA; OSTEOPOROSIS; PARENTERAL NUTRITION; REVIEW; RISK ASSESSMENT; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

CROHN DISEASE; HUMANS; INTERNET; NUTRITION PHYSIOLOGY; PATIENT EDUCATION AS TOPIC; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REMISSION INDUCTION;

EID: 47349087796     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2008.00048.x     Document Type: Review

References (116)

1. Birrenbach T, Bocker U. Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications. Inflamm Bowel Dis. 2004 10 : 848 859.
2. Loftus Jr EV, Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther. 2002 16 : 51 60.
3. Korzenik JR. Past and current theories of etiology of IBD: toothpaste, worms, and refrigerators. J Clin Gastroenterol. 2005 39 (Suppl S59 S65.
4. Schmidt C, Stallmach A. Etiology and pathogenesis of inflammatory bowel disease. Minerva Gastroenterol Dietol. 2005 51 : 127 145.
5. Sanders DS. Mucosal integrity and barrier function in the pathogenesis of early lesions in Crohn's disease. J Clin Pathol. 2005 58 : 568 572.
6. Sousa Guerreiro C, Cravo M, Costa AR, et al. A comprehensive approach to evaluate nutritional status in Crohn's patients in the era of biologic therapy: a case-control study. Am J Gastroenterol. 2007 102 : 2551 2556.
7. Thornton JR, Emmett PM, Heaton KW. Diet and Crohn's disease: characteristics of the pre-illness diet. BMJ. 1979 2 : 762 764.
8. O'Morain CA. Does nutritional therapy in inflammatory bowel disease have a primary or an adjunctive role? Scand J Gastroenterol. 1990 172 : 29 34.
9. Trebble TM. Bone turnover and nutritional status in Crohn's disease: relationship to circulating mononuclear cell function and response to fish oil and antioxidants. Proc Nutr Soc. 2005 64 : 183 191.
10. Adachi JD, Rostom A. Metabolic bone disease in adults with inflammatory bowel disease. Inflamm Bowel Dis. 1999 5 : 200 211.
11. Bernstein CN, Seeger LL, Sayre JW, Anton PA, Artinian L, Shanahan F. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. J Bone Mineral Res. 1995 10 : 250 256.
12. Harries AD, Brown R, Heatley RV, Williams LA, Woodhead S, Rhodes J. Vitamin D status in Crohn's disease: association with nutrition and disease activity. Gut. 1885 26 : 1197 1203.
13. Harpavat M, Greenspan SL, O'Brien C, Chang CC, Bowen A, Keljo DJ. Altered bone mass in children at diagnosis of Crohn disease: a pilot study. J Pediatr Gastroenterol Nutr. 2005 40 : 295 300.
14. Duggan P, O'Brien M, Kiely M, McCarthy J, Shanahan F, Cashman KD. Vitamin K status in patients with Crohn's disease and relationship to bone turnover. Am J Gastroenterol. 2004 99 : 2178 2185.
15. Lomer MC, Kodjabashia K, Hutchinson C, Greenfield SM, Thompson RP, Powell JJ. Intake of dietary iron is low in patients with Crohn's disease: a case-control study. Br J Nutr. 2004 91 : 141 148.
16. Goh J, O'Morain CA. Review article: nutrition and adult inflammatory bowel disease. Aliment Pharmacol Ther. 2003 17 : 307 320.
17. Kuroki F, Iida M, Tominaga M, et al. Multiple vitamin status in Crohn's disease. Correlation with disease activity. Dig Dis Sci. 1993 38 : 1614 1618.
18. Fernandez-Banares F, Abad-Lacruz A, et al. Vitamin status in patients with inflammatory bowel disease. Am J Gastroenterol. 1989 84 : 744 748.
19. Bousvaros A, Zurakowski D, Duggan C, et al. Vitamins A and E serum levels in children and young adults with inflammatory bowel disease: effect of disease activity. J Pediatr Gastroenterol Nutr. 1998 26 : 129 135.
20. Janczewska I, Bartnik W, Butruk E, Tomecki R, Kazik E, Ostrowski J. Metabolism of vitamin A in inflammatory bowel disease. Hepatogastroenterology. 1991 38 : 391 395.
21. Main AN, Mills PR, Russell RI, et al. Vitamin A deficiency in Crohn's disease. Gut. 1983 24 : 1169 1175.
22. Driscoll Jr JR, Meredith SC, Sitrin M, Wagonfeld JB, Rosenberg IH. Vitamin D deficiency and bone disease in patients with Crohn's disease. Gastroenterology 1982 83 : 1252 1258.
23. Socha P, Ryzko J, Koletzko B, et al. Essential fatty acid depletion in children with inflammatory bowel disease. Scand J Gastroenterol. 2005 40 : 573 577.
24. Fernandez-Banares F, Mingorance MD, Esteve M, et al. Serum zinc, copper, and selenium levels in inflammatory bowel disease: effect of total enteral nutrition on trace element status. Am J Gastroenterol. 1990 85 : 1584 1589.
25. Hendricks KM, Walker WA. Zinc deficiency in inflammatory bowel disease. Nutr Rev. 1988 46 : 401 408
26. Kuroki F, Matsumoto T, Lida M. Selenium is depleted in Crohn's disease on enteral nutrition. Dig Dis. 2003 21 : 266 270.
27. Hinks LJ, Inwards KD, Lloyd B, Clayton B. Reduced concentrations of selenium in mild Crohn's disease. J Clin Pathol. 1988 41 : 198 201.
28. Rannem T, Ladefoged K, Hylander E, Hegnhoj J, Jarnum S. Selenium status in patients with Crohn's disease. Am J Clin Nutr. 1992 56 : 933 937.
29. Main AN, Morgan RJ, Russell RI, et al. Mg deficiency in chronic inflammatory bowel disease and requirements during intravenous nutrition. JPEN J Parenter Enteral Nutr. 1981 5 : 15 19.
30. Buffinton GD, Doe WF. Depleted mucosal antioxidant defences in inflammatory bowel disease. Free Radic Biol Med. 1995 19 : 911 918.
31. Genser D, Kang MH, Vogelsang H, Elmadfa I. Status of lipid-soluble antioxidants and TRAP in patients with Crohn's disease and healthy controls. Eur J Clin Nutr. 1999 53 : 675 679.
32. Reimund JM, Hirth C, Koehl C, Baumann R, Duclos B. Antioxidant and immune status in active Crohn's disease. A possible relationship. Clin Nutr. 2000 19 : 43 48.
33. D'Odorico A, Bortolan S, Cardin R, et al. Reduced plasma antioxidant concentrations and increased oxidative DNA damage in inflammatory bowel disease. Scand J Gastroenterol. 2001 36 : 1289 1294.
34. Geerling BJ, Badart-Smook A, Stockbrügger RW, Brummer RJ. Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am J Clin Nutr. 1998 67 : 919 926.
35. Hoffenberg EJ, Deutsch J, Smith S, Sokol RJ. Circulating antioxidant concentrations in children with inflammatory bowel disease. Am J Clin Nutr. 1997 65 : 1482 1488.
36. Ojuawo A, Keith L. The serum concentrations of zinc, copper and selenium in children with inflammatory bowel disease. Cent Afr J Med. 2002 48 : 116 119.
37. Beattie RM. Enteral nutrition as primary therapy in childhood Crohn's disease: control of intestinal inflammation and anabolic response. JPEN J Parenter Enteral Nutr. 2005 29 (Suppl S151 S155.
38. Seidman EG, Roy CC, Weber AM, Morin CL. Nutritional therapy of Crohn's disease in childhood. Dig Dis Sci. 1987 32 (Suppl S82 S88.
39. Bresson JL, Schmitz J. Malnutrition in Crohn's disease: substrate deficiency or misuse? Horm Res. 1992 1 : 76 78.
40. Murch SH, Lamkin VA, Savage MO, Walker-Smith JA, MacDonald TT. Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease. Gut. 1991 32 : 913 917.
41. De Benedetti F, Alonzi T, Moretta A, et al. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J Clin Invest. 1997 99 : 643 650.
42. Ballinger AB, Azooz O, El-Haj T, Poole S, Farthing MJ. Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis. Gut. 2000 46 : 694 700.
43. Lionetti P, Callegari ML, Ferrari S, et al. Enteral nutrition and microflora in pediatric Crohn's disease. JPEN J Parenter Enteral Nutr. 2005 29 (Suppl S173 S175.
44. Morin CL, Roulet M, Roy CC, Weber A. Continuous elemental enteral alimentation in children with Crohn's disease and growth failure. Gastroenterology. 1980 79 : 1205 1210.
45. Belli DC, Seidman E, Bouthillier L, et al. Chronic intermittent elemental diet improves growth failure in children with Crohn's disease. Gastroenterology. 1988 94 : 603 610.
46. Israel DM, Hassall E. Prolonged use of gastrostomy for enteral hyperalimentation in children with Crohn's disease. Am J Gastroenterol. 1995 90 : 1084 1088.
47. Heuschkel R. Synergy between immunosuppressive therapy and enteral nutrition in the management of childhood Crohn's disease. JPEN J Parenter Enteral Nutr. 2005 29 (Suppl S160 S163.
48. Newby EA, Sawczenko A, Thomas AG, Wilson D. Interventions for growth failure in childhood Crohn's disease. Cochrane Database Syst Rev. 2005 3 : CD003873.
49. Griffiths AM. Enteral nutrition in the management of Crohn's disease. JPEN J Parenter Enteral Nutr. 2005 29 (Suppl S108 S112.
50. Homan M, Baldassano RN, Mamula P. Managing complicated Crohn's disease in children and adolescents. Nat Clin Pract Gastroenterol Hepatol. 2005 2 : 572 579.
51. Rufo PA, Bousvaros A. Challenges and progress in pediatric inflammatory bowel disease. Curr Opin Gastroenterol. 2007 23 : 406 412.
52. Rufo PA, Bousvaros A. Current therapy of inflammatory bowel disease in children. Paediatr Drugs. 2006 8 : 279 302.
53. Erichsen K, Hausken T, Ulvik RJ, Svardal A, Berstad A, Berge RK. Ferrous fumarate deteriorated plasma antioxidant status in patients with Crohn disease. Scand J Gastroenterol. 2003 38 : 543 548.
54. Spiegel JE, Willenbucher RF. Rapid development of severe copper deficiency in a patient with Crohn's disease receiving parenteral nutrition. JPEN J Parenter Enteral Nutr. 1999 23 : 169 172.
55. Andreassen H, Rix M, Brot C, Eskildsen P. Regulators of calcium homeostasis and bone mineral density in patients with Crohn's disease. Scand J Gastroenterol. 1998 33 : 1087 1093.
56. Andreassen H, Rungby J, Dahlerup JF, Mosekilde L. Inflammatory bowel disease and osteoporosis. Scand J Gastroenterol. 1997 32 : 1247 1255.
57. Schacht E. Rationale for treatment of involutional osteoporosis in women and for prevention and treatment of corticosteroid-induced osteoporosis with alfacalcidol. Calcif Tissue Int. 1997 65 : 317 327.
58. Siffledeen JS, Fedorak RN, Siminoski K, et al. Randomized trial of etidronate plus calcium and vitamin D for treatment of low bone mineral density in Crohn's disease. Clin Gastroenterol Hepatol. 2005 3 : 122 132.
59. Vogelsang H, Ferenci P, Resch H, Kiss A, Gangl A. Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation. Eur J Gastroenterol Hepatol. 1995 7 : 609 614.
60. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002 21 : 495 505.
61. Lorenz-Meyer H, Bauer P, Nicolay C, et al. Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Study Group Members (German Crohn's Disease Study Group). Scand J Gastroenterol. 1996 31 : 778 785.
62. Seidman E. Gastrointestinal benefits of enteral feeds. In : Baker S, Baker R, David A, eds. Pediatric Enteral Nutrition. New York : Chapman and Hall, 1994 : 46 66.
63. Kim YI. Can fish oil maintain Crohn's disease in remission? Nutr Rev. 1996 54 : 248 252.
64. Trebble TM, Arden NK, Wootton SA, et al. Fish oil and antioxidants alter the composition and function of circulating mononuclear cells in Crohn disease. Am J Clin Nutr. 2004 80 : 1137 1144.
65. Geerling BJ, Badart-Smook A, van Deursen C, et al. Nutritional supplementation with N-3 fatty acids and antioxidants in patients with Crohn's disease in remission: effects on antioxidant status and fatty acid profile. Inflamm Bowel Dis. 2000 6 : 77 84.
66. Belluzzi A. N-3 fatty acids for the treatment of inflammatory bowel diseases. Proc Nutr Soc. 2002 61 : 391 395.
67. Macdonald A. Omega-3 fatty acids as adjunctive therapy in Crohns disease. Gastroenterol Nurs. 2006 29 : 295 301.
68. Turner D, Zlotkin SH, Shah PS, Griffiths AM. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev. 2007 2 : CD006320.
69. Galland L. Magnesium and inflammatory bowel disease. Magnesium. 1988 7 : 78 83.
70. McKenzie S, Baker M, Buffinton G, Doe W. Evidence of oxidant induced injury to epithelial cells during inflammatory bowel disease. J Clin Invest. 1996 98 : 136 141.
71. Aghdassi E, Wendland BE, Steinhart AH, Wolman SL, Jeejeebhoy K, Allard JP. Antioxidant vitamin supplementation in Crohn's disease decreases oxidative stress. A randomized controlled trial. Am J Gastroenterol. 2003 98 : 348 353.
72. Emerit J, Pelletier S, Likforman J, Pasquier C, Thuillier A. Phase II trial of copper zinc superoxide dismutase (CuZn SOD) in the treatment of Crohn's disease. Free Radic Res Commun. 1991 12-13 : 563 569.
73. Kudsk KA, Wu Y, Fukatsu K, et al. Glutamine-enriched total parenteral nutrition maintains intestinal interleukin-4 and mucosal immunoglobulin A levels. JPEN J Parenter Enteral Nutr. 2000 24 : 270 275.
74. Akobeng AK, Miller V, Stanton J, Elbadri AM, Thomas AG. Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease. J Pediatr Gastroenterol Nutr. 2000 30 : 78 84.
75. Galvez J, Rodriguez-Cabezas ME, Zarzuelo A. Effects of dietary fiber on inflammatory bowel disease. Mol Nutr Food Res. 2005 49 : 601 608.
76. Heaton KW, Thornton JR, Emmett PM. Treatment of Crohn's disease with an unrefined-carbohydrate, fibre-rich diet. BMJ. 1979 2 : 764 766.
77. Ritchie JK, Wadsworth J, Lennard-Jones JE, Rogers E. Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn's disease. BMJ Clin Res Ed. 1987 295 : 517 520.
78. Klurfeld DM. The role of dietary fiber in gastrointestinal disease. J Am Dietet Assoc. 1987 87 : 1172 1177.
79. Riemann JF, Kolb S. Low-sugar and fiber-rich diet in Crohn disease. Fortschritte der Medizin. 1984 102 : 67 70.
80. Persson PG, Ahlbom A, Hellers G. Diet and inflammatory bowel disease: a case-control study. Epidemiology. 1992 3 : 47 52.
81. Zutshi M, Hull TL, Hammel J. Crohn's disease: a patient's perspective. Int J Colorect Dis. 2007 22 : 1437 1444.
82. Voitk AJ, Echave V, Feller JH, Brown RA, Gurd FN. Experience with elemental diet in the treatment of inflammatory bowel disease. Is this a primary therapy? Arch Surg. 1973 107 : 319 333.
83. Bowling TE, Jameson JJ, Grimble GK, Silk DBA. Enteral nutrition as a primary therapy in active Crohn's disease. Eur J Gastroenterol Hepatol. 1993 5 : 1 7.
84. Ruemmele FM, Roy CR, Levy E, Seidman EG. Nutrition as primary therapy in pediatric Crohn's disease: fact or fantasy? J Pediatr. 2000 136 : 285 291.
85. Lochs H. To feed or not to feed? Are nutritional supplements worthwhile in active Crohn's disease? Gut. 2006 55 : 306 307.
86. O'Morain C, Segal AW, Levi AJ. Elemental diet as primary treatment of acute Crohn's disease: a controlled trial. BMJ. 1984 288 : 1859 1862.
87. Sanderson IR, Udeen S, Davies PSW, Savage MO, Walker-Smith JA. Remission induced by an elemental diet in small bowel Crohn's disease. Arch Dis Chile. 1987 61 : 123 127.
88. Gonzalez-Huix F, de Leon R, Fernandez-Banares F, et al. Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial. Gut. 1993 34 : 778 782.
89. Gorard DA, Hunt JB, Payne-James JJ, et al. Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone. Gut. 1993 34 : 1198 1202.
90. Ruuska T, Savilahti E, Maki M, Ormala T, Visakorpi JK. Exclusive whole protein enteral diet versus prednisolone in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr. 1994 19 : 175 180.
91. Teahon K, Pearson M, Levi AJ, Bjarnason I. Practical aspects of enteral nutrition in the management of Crohn's disease. Parenter Enteral Nutr. 1995 19 : 365 368.
92. Seidman GE, Lohoues MJ, Turgeon J, Bouthillier L, Morin CL. Elemental diet versus prednisone as initial therapy in Crohn's disease: early and long term results. Gastroenterology. 1991 100 : 250A.
93. Mansfield JC, Giaffer MH, Holdsworth CD. Controlled trial of oligopeptide versus amino acid diet in treatment of active Crohn's disease. Gut. 1995 36 : 60 66.
94. Middleton SJ, Rucker JT, Kirby GA, Riordan AM, Hunter JO. Long-chain triglycerides reduce the efficacy of enteral feeds in patients with active Crohn's disease. Clin Nutr. 1995 14 : 229 236.
95. Raouf AH, Hildrey V, Daniel J, et al. Enteral feeding as sole treatment for Crohn's disease: controlled trial of whole protein vs. amino acid based feed and a case study of dietary challenge. Gut. 1991 32 : 702 707.
96. Rigaud D, Cosnes J, Le Quintrec Y, Rene E, Gendre JP, Mignon M. Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease: elemental vs. polymeric diet. Gut. 1991 32 : 1492 1497.
97. Royall D, Jeejeebhoy KN, Baker JP, et al. Comparison of amino acid vs. peptide based enteral diets in active Crohn's disease: clinical and nutritional outcome. Gut. 1994 35 : 783 787.
98. Messori A, Trallori G, D'Albasio G, Milla M, Vannozzi G, Pacini F. Defined-formula diets versus steroids in the treatment of active Crohn's disease: a meta-analysis. Scand J Gastroenterol. 1996 31 : 267 272.
99. Griffiths AM, Ohlsson A, Sherman PM, Sutherland LR. Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease. Gastroenterology. 1995 108 : 1057 1067.
100. Fernandez-Banares F, Cabre E, Esteve-Comas M, Gassull MA. How effective is enteral nutrition in inducing clinical remission in active Crohn's disease? A meta-analysis of the randomized clinical trials. J Parenteral Enteral Nutr. 1995 19 : 1056 1064.
101. Verma S, Brown S, Kirkwood B, Giaffer MH. Polymeric versus elemental diet as primary treatment in active Crohn's disease: a randomized, double-blind trial. Am J Gastroenterol. 2000 95 : 735 739.
102. Fell JM. Control of systemic and local inflammation with transforming growth factor beta containing formulas. J Parenter Enteral Nutr. 2005 29 (Suppl S126 S128.
103. Park RHR, Galloway A, Danesh BJZ, et al. Double-blind controlled trial comparing elemental, and polymeric diets as primary therapy in active Crohn's disease. Eur J Gastroenterol Hepatol. 1991 32 : 1492 1497.
104. Sanderson IR, Croft NM. The anti-inflammatory effects of enteral nutrition. J Parenter Enteral Nutr. 2005 29 (Suppl S134 S140.
105. Shaoul R The importance of nutrition in inflammatory bowel disease in children Harefuah. 2005 144 : 564 566.
106. Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for inducing remission in Crohn's disease. Cochrane Database Syst Rev. 2001 3 : CD000542.
107. Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2007 1 : CD000542.
108. Driscoll Jr RH, Rosenberg IH. Total parenteral nutrition in inflammatory bowel disease. Med Clin North Am. 1978 62 : 185 201.
109. Messing B Parenteral nutrition: indications and techniques Ann Med Interne (Paris). 2000 151 : 652 658.
110. Keller KM, Wirth S Parenteral nutrition in treatment of short stature in adolescents with Crohn disease Klin Padiatr. 1992 204 : 411 416.
111. Strobel CT, Byrne WJ, Ament ME. Home parenteral nutrition in children with Crohn's disease: an effective management alternative. Gastrenterology. 1979 77 : 272 279.
112. Campos FG, Waitzberg DL, Teixeira MG, Mucerino DR, Habr-Gama A, Kiss DR. Inflammatory bowel diseases: principles of nutritional therapy. Rev Hosp Clin Fac Med Sao Paulo. 2002 57 : 187 198.
113. Shiloni E, Coronado E, Freund HR. Role of total parenteral nutrition in the treatment of Crohn's disease. Am J Surg. 1989 157 : 180 185.
114. Meier R, Steuerwald M. Place of probiotics. Curr Opin Crit Care. 2005 11 : 318 325.
115. Hedin C, Whelan K, Lindsay JO. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. Proc Nutr Soc. 2007 66 : 307 315.
116. Rolfe VE, Fortun PJ, Hawkey CJ, Bath-Hextall F. Probiotics for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev. 2006 4 : CD004826.